Skip to content
Insider tapeFilings through Fri, Oct 16
Watchlist

Ingmar Bruns

Chief Medical Officer at Zentalis Pharmaceuticals, Inc. (ZNTL)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $8K

Reported trades

Filed Stock Type Shares Price Value Since
Feb 10SEC ZNTLZentalis Pharmaceuticals, Inc. Sell 2,96233,667 held (−8%) $2.43 $7K -12.3%
Feb 10SEC ZNTLZentalis Pharmaceuticals, Inc. Sell 33533,332 held (−1%) $2.39 $801 -10.9%